PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Aug-2022 Full Day Virtual Seminar on Fundamentals of Toxicology - ResearchAndMarkets.com Businesswire
09-Aug-2022 BeiGene Announces Positive Global Phase 3 Trial Results for PD-1 Inhibitor Tislelizumab in First-Line Unresectable Hepatocellular Cancer Businesswire
09-Aug-2022 AFFLINK Grows Leadership Team Businesswire
09-Aug-2022 Biodesix Named a Top 100 Healthcare Technology Company of 2022 Businesswire
09-Aug-2022 North America Bioanalytical Testing Services Market Report 2022: Rising Demand for Analytical Testing of Biologics and Biosimilars & Increasing Preference for Outsourcing Driving Growth - ResearchAndMarkets.com Businesswire
09-Aug-2022 Germany Cold Chain Logistics Market Report 2022: Pharmaceutical Industry Demand for Advanced Cold-Chain Services Driving Growth - ResearchAndMarkets.com Businesswire
09-Aug-2022 Dravet Syndrome Treatment Market Report 2022-2029: Stiripentol and Cannabidiol to Contribute to Significant Growth of 11.7% - ResearchAndMarkets.com Businesswire
09-Aug-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
09-Aug-2022 Cansativa Group and Akanda Corp. to Bring New Medical Cannabis Flowers to Germany Businesswire
09-Aug-2022 Nearly 1 in 2 Junior Doctors Are Considering Leaving Their Profession, Medscape UK Report Finds Businesswire
09-Aug-2022 Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson Businesswire
08-Aug-2022 Invacare Reports Results for Second Quarter 2022 Businesswire
08-Aug-2022 Scholar Rock Reports Second Quarter 2022 Financial Results and Highlights Business Progress Businesswire
08-Aug-2022 Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update Businesswire
08-Aug-2022 Arcus Biosciences Appoints Dimitry Nuyten, M.D., Ph.D. as Chief Medical Officer Businesswire
08-Aug-2022 Applied DNA to Host Conference Call and Webcast Discussing Fiscal 2022 Third Quarter Results and Corporate Updates Businesswire
08-Aug-2022 Tricida Announces Second Quarter 2022 Financial Results Businesswire
08-Aug-2022 Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2022 With Webcast and Conference Call Today at 4:30 p.m. ET Businesswire
08-Aug-2022 CVD Equipment to Announce 2022 Second Quarter Results Businesswire
08-Aug-2022 Ligand Reports Second Quarter 2022 Financial Results Businesswire